consumer concerns

Biotechnology company Regeneron buying bankrupt 23andMe for $256M
"We believe we can help 23andMe deliver and build upon its mission to help people learn about their own DNA and how to improve their personal health, while furthering Regeneron's efforts to improve the health and wellness of many," Regeneron co-founder George Yancopoulos said.
More Stories
More Stories